NEO
Diagnostics & Research · Healthcare
Head of Investor Relations
Head of Investor Relations
Neogenomics Inc (NEO)Equibles does not estimate personal net worth.
Get an email with a short summary when Neogenomics Inc publishes a filing, an earnings call transcript or a press release.
Get NEO alertsCharlie Eidson is recorded as Head of Investor Relations at Neogenomics Inc (NEO). Charlie Eidson has spoken on 6 earnings calls across 1 company, most recently for Neogenomics Inc on April 27, 2022. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Neogenomics Inc includes Chris Smith (CEO and Board Member), Christopher Smith (CEO and Board Member), Lynn A. Tetrault (CEO, Chairman and Board Member) and 7 others.
“This conference call includes forward-looking statements about our 2022 initiatives, financial outlook, growth opportunities, and anticipated operating results and performance.”
“This conference call includes forward-looking statements about our 2022 initiatives, 2022 financial outlook, growth opportunities, and anticipated operating results and performance.”
“This conference call may contain forward-looking statements, which represent our current expectations and beliefs about our operations, performance, financial condition, and growth opportunities.”
“This conference call may contain forward-looking statements, which represent our current expectations and beliefs about our operations, performance, financial condition, and growth opportunities.”
“This conference call may contain forward-looking statements, which represent our current expectations and beliefs about our operations, performance, financial condition and growth opportunities.”
NEO
Diagnostics & Research · Healthcare
Head of Investor Relations